Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Hypertension: HELP
Articles from Maryland
Based on 1,383 articles published since 2008

These are the 1383 published articles about Hypertension that originated from Maryland during 2008-2019.
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. 2019

Elmets, Craig A / Leonardi, Craig L / Davis, Dawn M R / Gelfand, Joel M / Lichten, Jason / Mehta, Nehal N / Armstrong, April W / Connor, Cody / Cordoro, Kelly M / Elewski, Boni E / Gordon, Kenneth B / Gottlieb, Alice B / Kaplan, Daniel H / Kavanaugh, Arthur / Kivelevitch, Dario / Kiselica, Matthew / Korman, Neil J / Kroshinsky, Daniela / Lebwohl, Mark / Lim, Henry W / Paller, Amy S / Parra, Sylvia L / Pathy, Arun L / Prater, Elizabeth Farley / Rupani, Reena / Siegel, Michael / Stoff, Benjamin / Strober, Bruce E / Wong, Emily B / Wu, Jashin J / Hariharan, Vidhya / Menter, Alan. ·University of Alabama, Birmingham, Alabama. · Central Dermatology, St. Louis, Missouri. · Mayo Clinic, Rochester, Minnesota. · University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · National Psoriasis Foundation, Portland, Oregon. · National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland. · University of Southern California, Los Angeles, California. · Department of Dermatology, University of California San Francisco School of MedicineSan Francisco, California. · Medical College of Wisconsin, Milwaukee, Wisconsin. · Department of Dermatology, Icahn School of Medicine at Mt. Sinai, New York, New York. · University of Pittsburgh, Pennsylvania. · University of California San Diego, San Diego, California. · Baylor Scott and White, Dallas, Texas. · University Hospitals Cleveland Medical Center, Cleveland, Ohio. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Dermatology, Henry Ford Hospital, Detroit, Michigan. · Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Dermatology and Skin Surgery, Sumter, South Carolina. · Colorado Permanente Medical Group, Centennial, Colorado. · University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Icahn School of Medicine at Mount Sinai, New York, New York. · Emory University School of Medicine, Atlanta, Georgia. · University of Connecticut, Farmington, Connecticut; Probity Medical Research, Waterloo, Canada. · San Antonio Uniformed Services Health Education Consortium, Joint-Base San Antonio, Texas. · Dermatology Research and Education Foundation, Irvine, California. · American Academy of Dermatology, Rosemont, Illinois. Electronic address: vhariharan@aad.org. ·J Am Acad Dermatol · Pubmed #30772097.

ABSTRACT: Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations on the basis of available evidence.

2 Guideline ACR Appropriateness Criteria 2017

Anonymous7910925 / Harvin, Howard J / Verma, Nupur / Nikolaidis, Paul / Hanley, Michael / Dogra, Vikram S / Goldfarb, Stanley / Gore, John L / Savage, Stephen J / Steigner, Michael L / Strax, Richard / Taffel, Myles T / Wong-You-Cheong, Jade J / Yoo, Don C / Remer, Erick M / Dill, Karin E / Lockhart, Mark E. ·Principal Author, Scottsdale Medical Imaging, Scottsdale, Arizona. Electronic address: h_harvin@yahoo.com. · Co-author, University of Florida, Gainesville, Florida. · Panel Vice Chair (Urologic), Northwestern University, Chicago, Illinois. · Panel Vice Chair (Vascular), University of Virginia Health System, Charlottesville, Virginia. · University of Rochester Medical Center, Rochester, New York. · University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; American Society of Nephrology. · University of Washington, Seattle, Washington; American Urological Association. · Medical University of South Carolina, Charleston, South Carolina; American Urological Association. · Brigham & Women's Hospital, Boston, Massachusetts. · Baylor College of Medicine, Houston, Texas. · George Washington University Hospital, Washington, District of Columbia. · University of Maryland School of Medicine, Baltimore, Maryland. · Rhode Island Medical Imaging Inc., East Providence, Rhode Island. · Specialty Chair (Urologic), Cleveland Clinic, Cleveland, Ohio. · Panel Chair (Vascular), UMass Memorial Medical Center, Worcester, Massachusetts. · Panel Chair (Urologic), University of Alabama at Birmingham, Birmingham, Alabama. ·J Am Coll Radiol · Pubmed #29101991.

ABSTRACT: Renovascular hypertension is the most common type of secondary hypertension and is estimated to have a prevalence between 0.5% and 5% of the general hypertensive population, and an even higher prevalence among patients with severe hypertension and end-stage renal disease, approaching 25% in elderly dialysis patients. Investigation for renal artery stenosis is appropriate when clinical presentation suggests secondary hypertension rather than primary hypertension, when there is not another known cause of secondary hypertension, and when intervention would be carried out if a significant renal artery stenosis were identified. The primary imaging modalities used to screen for renal artery stenosis are CT, MRI, and ultrasound, with the selection of imaging dependent in part on renal function. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

3 Guideline Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. 2017

Flynn, Joseph T / Kaelber, David C / Baker-Smith, Carissa M / Blowey, Douglas / Carroll, Aaron E / Daniels, Stephen R / de Ferranti, Sarah D / Dionne, Janis M / Falkner, Bonita / Flinn, Susan K / Gidding, Samuel S / Goodwin, Celeste / Leu, Michael G / Powers, Makia E / Rea, Corinna / Samuels, Joshua / Simasek, Madeline / Thaker, Vidhu V / Urbina, Elaine M / Anonymous5820916. ·Dr. Robert O. Hickman Endowed Chair in Pediatric Nephrology, Division of Nephrology, Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Washington; joseph.flynn@seattlechildrens.org. · Departments of Pediatrics, Internal Medicine, Population and Quantitative Health Sciences, Center for Clinical Informatics Research and Education, Case Western Reserve University and MetroHealth System, Cleveland, Ohio. · Division of Pediatric Cardiology, School of Medicine, University of Maryland, Baltimore, Maryland. · Children's Mercy Hospital, University of Missouri-Kansas City and Children's Mercy Integrated Care Solutions, Kansas City, Missouri. · Department of Pediatrics, School of Medicine, Indiana University, Bloomington, Indiana. · Department of Pediatrics, School of Medicine, University of Colorado-Denver and Pediatrician in Chief, Children's Hospital Colorado, Aurora, Colorado. · Director, Preventive Cardiology Clinic, Boston Children's Hospital, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts. · Division of Nephrology, Department of Pediatrics, University of British Columbia and British Columbia Children's Hospital, Vancouver, British Columbia, Canada. · Departments of Medicine and Pediatrics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania. · Consultant, American Academy of Pediatrics, Washington, District of Columbia. · Cardiology Division Head, Nemours Cardiac Center, Alfred I. duPont Hospital for Children, Wilmington, Delaware. · National Pediatric Blood Pressure Awareness Foundation, Prairieville, Louisiana. · Departments of Pediatrics and Biomedical Informatics and Medical Education, University of Washington, University of Washington Medicine and Information Technology Services, and Seattle Children's Hospital, Seattle, Washington. · Department of Pediatrics, School of Medicine, Morehouse College, Atlanta, Georgia. · Associate Director, General Academic Pediatric Fellowship, Staff Physician, Boston's Children's Hospital Primary Care at Longwood, Instructor, Harvard Medical School, Boston, Massachusetts. · Departments of Pediatrics and Internal Medicine, McGovern Medical School, University of Texas, Houston, Texas. · Pediatric Education, University of Pittsburgh Medical Center Shadyside Family Medicine Residency, Clinical Associate Professor of Pediatrics, Children's Hospital of Pittsburgh of University of Pittsburgh Medical Center, and School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. · Division of Molecular Genetics, Department of Pediatrics, Columbia University Medical Center, New York, New York; and. · Preventive Cardiology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio. ·Pediatrics · Pubmed #28827377.

ABSTRACT: These pediatric hypertension guidelines are an update to the 2004 "Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents." Significant changes in these guidelines include (1) the replacement of the term "prehypertension" with the term "elevated blood pressure," (2) new normative pediatric blood pressure (BP) tables based on normal-weight children, (3) a simplified screening table for identifying BPs needing further evaluation, (4) a simplified BP classification in adolescents ≥13 years of age that aligns with the forthcoming American Heart Association and American College of Cardiology adult BP guidelines, (5) a more limited recommendation to perform screening BP measurements only at preventive care visits, (6) streamlined recommendations on the initial evaluation and management of abnormal BPs, (7) an expanded role for ambulatory BP monitoring in the diagnosis and management of pediatric hypertension, and (8) revised recommendations on when to perform echocardiography in the evaluation of newly diagnosed hypertensive pediatric patients (generally only before medication initiation), along with a revised definition of left ventricular hypertrophy. These guidelines include 30 Key Action Statements and 27 additional recommendations derived from a comprehensive review of almost 15 000 published articles between January 2004 and July 2016. Each Key Action Statement includes level of evidence, benefit-harm relationship, and strength of recommendation. This clinical practice guideline, endorsed by the American Heart Association, is intended to foster a patient- and family-centered approach to care, reduce unnecessary and costly medical interventions, improve patient diagnoses and outcomes, support implementation, and provide direction for future research.

4 Guideline 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). 2014

James, Paul A / Oparil, Suzanne / Carter, Barry L / Cushman, William C / Dennison-Himmelfarb, Cheryl / Handler, Joel / Lackland, Daniel T / LeFevre, Michael L / MacKenzie, Thomas D / Ogedegbe, Olugbenga / Smith, Sidney C / Svetkey, Laura P / Taler, Sandra J / Townsend, Raymond R / Wright, Jackson T / Narva, Andrew S / Ortiz, Eduardo. ·University of Iowa, Iowa City. · University of Alabama at Birmingham School of Medicine. · Memphis Veterans Affairs Medical Center and the University of Tennessee, Memphis. · Johns Hopkins University School of Nursing, Baltimore, Maryland. · Kaiser Permanente, Anaheim, California. · Medical University of South Carolina, Charleston. · University of Missouri, Columbia. · Denver Health and Hospital Authority and the University of Colorado School of Medicine, Denver. · New York University School of Medicine, New York, New York. · University of North Carolina at Chapel Hill. · Duke University, Durham, North Carolina. · Mayo Clinic College of Medicine, Rochester, Minnesota. · University of Pennsylvania, Philadelphia. · Case Western Reserve University, Cleveland, Ohio. · National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland. · at the time of the project,National Heart, Lung, and Blood Institute, Bethesda, Maryland17currently with ProVation Medical, Wolters Kluwer Health, Minneapolis, Minnesota. ·JAMA · Pubmed #24352797.

ABSTRACT: Hypertension is the most common condition seen in primary care and leads to myocardial infarction, stroke, renal failure, and death if not detected early and treated appropriately. Patients want to be assured that blood pressure (BP) treatment will reduce their disease burden, while clinicians want guidance on hypertension management using the best scientific evidence. This report takes a rigorous, evidence-based approach to recommend treatment thresholds, goals, and medications in the management of hypertension in adults. Evidence was drawn from randomized controlled trials, which represent the gold standard for determining efficacy and effectiveness. Evidence quality and recommendations were graded based on their effect on important outcomes. There is strong evidence to support treating hypertensive persons aged 60 years or older to a BP goal of less than 150/90 mm Hg and hypertensive persons 30 through 59 years of age to a diastolic goal of less than 90 mm Hg; however, there is insufficient evidence in hypertensive persons younger than 60 years for a systolic goal, or in those younger than 30 years for a diastolic goal, so the panel recommends a BP of less than 140/90 mm Hg for those groups based on expert opinion. The same thresholds and goals are recommended for hypertensive adults with diabetes or nondiabetic chronic kidney disease (CKD) as for the general hypertensive population younger than 60 years. There is moderate evidence to support initiating drug treatment with an angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, calcium channel blocker, or thiazide-type diuretic in the nonblack hypertensive population, including those with diabetes. In the black hypertensive population, including those with diabetes, a calcium channel blocker or thiazide-type diuretic is recommended as initial therapy. There is moderate evidence to support initial or add-on antihypertensive therapy with an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in persons with CKD to improve kidney outcomes. Although this guideline provides evidence-based recommendations for the management of high BP and should meet the clinical needs of most patients, these recommendations are not a substitute for clinical judgment, and decisions about care must carefully consider and incorporate the clinical characteristics and circumstances of each individual patient.

5 Guideline ASH Position Paper: Dietary approaches to lower blood pressure. 2009

Appel, Lawrence J / Anonymous2090633 / Giles, Thomas D / Black, Henry R / Izzo, Joseph L / Materson, Barry J / Oparil, Suzanne / Weber, Michael A. ·Department of Medicine, Division of General Internal Medicine, Johns Hopkins University, Baltimore, MD 21205-2223, USA. lappel@jhmi.edu ·J Clin Hypertens (Greenwich) · Pubmed #19583632.

ABSTRACT: A substantial body of evidence has implicated several aspects of diet in the pathogenesis of elevated blood pressure (BP). Well-established risk factors for elevated BP include excess salt intake, low potassium intake, excess weight, high alcohol consumption, and suboptimal dietary pattern. African Americans are especially sensitive to the BP-raising effects of excess salt intake, insufficient potassium intake, and suboptimal diet. In this setting, dietary changes have the potential to substantially reduce racial disparities in BP and its consequences. In view of the age-related rise in BP in both children and adults, the direct, progressive relationship of BP with cardiovascular-renal diseases throughout the usual range of BP, and the worldwide epidemic of BP-related disease, efforts to reduce BP in nonhypertensive as well as hypertensive individuals are warranted. In nonhypertensives, dietary changes can lower BP and delay, if not prevent, hypertension. In uncomplicated stage I hypertension, dietary changes serve as initial treatment before drug therapy. In hypertensive individuals already on drug therapy, lifestyle modifications can further lower BP. The current challenge is designing and implementing effective clinical and public health interventions that lead to sustained dietary changes among individuals and more broadly in the general population.

6 Editorial Supply and Demand: Micro(vascular) Economics of the Right Ventricle in Pulmonary Hypertension. 2018

Kolb, Todd M / Hassoun, Paul M. ·1 Department of Medicine Johns Hopkins University School of Medicine Baltimore, Maryland. ·Am J Respir Cell Mol Biol · Pubmed #29995431.

ABSTRACT: -- No abstract --

7 Editorial Obesity, Hypertension, and Dyslipidemia in Childhood Are Key Modifiable Antecedents of Adult Cardiovascular Disease: A Call to Action. 2018

Turer, Christy B / Brady, Tammy M / de Ferranti, Sarah D. ·Departments of Pediatrics, Internal Medicine, and Clinical Sciences, University of Texas Southwestern Medical School, Harold C. Simmons Cancer Center, and Children's Health System of Dallas (C.B.T.) christy.turer@utsouthwestern.edu. · Department of Pediatrics, Division of Pediatric Nephrology, Johns Hopkins School of Medicine, Baltimore, MD (T.M.B.). · Department of Cardiology, Boston Children's Hospital and Harvard Medical School, MA (S.D.d.F.). ·Circulation · Pubmed #29555708.

ABSTRACT: -- No abstract --

8 Editorial Next Steps for Gene Identification in Primary Hypertension Genomics. 2017

Ehret, Georg. ·From Cardiology, Department of Specialties of Medicine, Geneva University Hospitals, Switzerland; and Center for Complex Disease Genomics, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. georg.ehret@hcuge.ch. ·Hypertension · Pubmed #28784647.

ABSTRACT: -- No abstract --

9 Editorial Intersection of 2 Epidemics: Asthma and Cardiovascular Disease. 2017

Gottdiener, John S. ·Division of Cardiology, Department of Medicine, University of Maryland Medical Center, Baltimore, Maryland. Electronic address: jgottdie@medicine.umaryland.edu. ·JACC Heart Fail · Pubmed #28662938.

ABSTRACT: -- No abstract --

10 Editorial Burning Redoxstats in the Brainstem: Lack of Nrf2 and the Rise of Hypertension. 2017

Paolocci, Nazareno / Cannavo, Alessandro / Chelko, Stephen P / Montano, Nicola. ·From the Division of Cardiology, Johns Hopkins Medical Institutions, Baltimore, MD (N.P., S.P.C.) · Department of Experimental Medicine, Universita' di Perugia, Italy (N.P.) · Lewis Katz School of Medicine, Temple University, Philadelphia, PA (A.C.) · and Fondazione IRCSS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy · Department of Clinical Sciences and Community Health, University of Milan, Italy (N.M.). ·Hypertension · Pubmed #28461602.

ABSTRACT: -- No abstract --

11 Editorial The Sounds of Progress. 2017

Ashar, Bimal H. ·Division of General Internal Medicine, Johns Hopkins University School of Medicine, 601 North Caroline Street, #7143, Baltimore, MD 21287, USA. Electronic address: Bashar1@jhmi.edu. ·Med Clin North Am · Pubmed #27884240.

ABSTRACT: -- No abstract --

12 Editorial Booker T. Washington and the Secret of Hypertension in African Americans. 2016

Mackowiak, Philip A. ·Department of Medicine, University of Maryland School of Medicine, Baltimore, MD. Electronic address: Philip.mackowiak@va.gov. ·Am J Med Sci · Pubmed #27776724.

ABSTRACT: Booker T. Washington rose from slavery to become one of the most admired Americans of his time. He died of long-standing malignant hypertension on November 14, 1915. At that time the medical profession was just beginning to recognize the importance of hypertension as a risk factor for cardiovascular disease. In spite of intensive research fueled by ongoing speculation, why Washington might have been predisposed to the ravages of hypertension, and African Americans continue to be so predisposed, is a secret yet to be told.

13 Editorial Hypertension and Target Organ Damage: Don't Believe Everything You Think! 2016

Mensah, George A. ·Center for Translation Research and Implementation Science; National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, Maryland, USA; Division of Cardiovascular Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, Maryland, USA. ·Ethn Dis · Pubmed #27440965.

ABSTRACT: -- No abstract --

14 Editorial SPRINT and Implications for Target Organ Protection in African Americans. 2016

Wright, Jackson T Jr / Fine, Lawrence J. ·Division of Nephrology and Hypertension, University Hospitals Case Medical Center, Cleveland, Ohio. · Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Md. ·Ethn Dis · Pubmed #27440964.

ABSTRACT: -- No abstract --

15 Editorial What Defines a Valuable Investment in Global Health Research? 2016

Bloomfield, Gerald S / Narayan, K M Venkat / Sampson, Uchechukwu K A / Narula, Jagat. ·Department of Medicine, Duke University Medical Center, Duke Clinical Research Institute, and Duke Global Health Institute, Duke University, Durham, NC, USA. · Emory Global Diabetes Research Center, Rollins School of Public Health, Emory University, Atlanta, GA, USA. · Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. · Department of Medicine, Mount Sinai Hospital, New York, NY, USA. Electronic address: jagat.narula@mountsinai.org. ·Glob Heart · Pubmed #27102017.

ABSTRACT: -- No abstract --

16 Editorial The merging burden of HIV infection and stroke in the developing world. 2016

Behrouz, Réza / Gottesman, Rebecca F. ·From the Department of Neurology (R.B.), School of Medicine, University of Texas Health Science Center, San Antonio · and the Department of Neurology (R.F.G.), Johns Hopkins University School of Medicine, Baltimore, MD. ·Neurology · Pubmed #26683640.

ABSTRACT: -- No abstract --

17 Editorial Novel therapeutics in hypertension and kidney disease. 2015

Sperati, C John / Whaley-Connell, Adam. ·aDepartment of Medicine, Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, Maryland bResearch Service, Harry S Truman Memorial Veterans Hospital and the University of Missouri-Columbia School of Medicine cDepartment of Internal Medicine, Divisions of Nephrology and Hypertension and Endocrinology and Metabolism, Columbia, Missouri, USA. ·Curr Opin Nephrol Hypertens · Pubmed #26181780.

ABSTRACT: -- No abstract --

18 Editorial Blood pressure and cerebral ischemia: a continuing dilemma. 2014

Gottesman, Rebecca F / Chalmers, John. ·From the Department of Neurology (R.F.G.), Johns Hopkins University School of Medicine, Baltimore, MD · and The George Institute for Global Health (J.C.), Sydney, Australia. ·Neurology · Pubmed #24532272.

ABSTRACT: -- No abstract --

19 Editorial Screening blood pressure measurement in children: are we saving lives? 2014

Brady, Tammy M / Redwine, Karen M / Flynn, Joseph T / Anonymous3841063. ·Division of Nephrology, Department of Pediatrics, Johns Hopkins University, Baltimore, MD, USA. ·Pediatr Nephrol · Pubmed #24326788.

ABSTRACT: Blood Pressure screening in children and adolescents is currently recommended by several prominent medical organizations, including the American Heart Association, the National High Blood Pressure Education Program, the National Heart, Lung, and Blood Institute, the European Society of Hypertension, and the American Academy of Pediatrics. This practice was recently subject to intense scientific review by the U.S. Preventive Services Task Force. The conclusion of the Task Force was that "current evidence is insufficient to assess the balance of benefits and harms of screening for primary hypertension in asymptomatic children and adolescents." This commentary provides an alternate interpretation of current evidence for blood pressure screening in children and adolescents and highlights its importance as a part of routine medical care.

20 Editorial Refractory hypertension: an important clinical phenotype. 2014

Weir, Matthew R / Townsend, Raymond R. ·Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD. mweir@medicine.umaryland.edu. ·Hypertension · Pubmed #24324052.

ABSTRACT: -- No abstract --

21 Editorial When implausible findings emanate from high-quality studies. 2011

Sorlie, Paul D. ·Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. sorliep@mail.nih.gov ·Epidemiology · Pubmed #21642776.

ABSTRACT: -- No abstract --

22 Review Hypertensive Disorders of Pregnancy. 2019

Wilkerson, R Gentry / Ogunbodede, Adeolu C. ·Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, Suite 200; 6th Floor, Baltimore, MD 21201, USA. Electronic address: gwilkerson@som.umaryland.edu. · Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, Suite 200; 6th Floor, Baltimore, MD 21201, USA; Department of Internal Medicine, University of Maryland School of Medicine, 110 South Paca Street, Suite 200; 6th Floor, Baltimore, MD 21201, USA. ·Emerg Med Clin North Am · Pubmed #30940374.

ABSTRACT: The 4 categories of hypertensive disorders of pregnancy are chronic hypertension, gestational hypertension, preeclampsia-eclampsia, and chronic hypertension with superimposed preeclampsia. These disorders are among the leading causes of maternal and fetal morbidity and mortality. Proper diagnosis in the emergency department is crucial in order to initiate appropriate treatment to reduce the potential harm to the mother and the fetus. Prompt management should be undertaken when the blood pressure is greater than 160/110 mm Hg or there are other severe features such as acute kidney injury, elevated liver function tests, severe abdominal pain, pulmonary edema, and central nervous system disturbances.

23 Review Intracerebral haemorrhage: current approaches to acute management. 2018

Cordonnier, Charlotte / Demchuk, Andrew / Ziai, Wendy / Anderson, Craig S. ·University of Lille, Inserm U1171, Degenerative and Vascular Cognitive Disorders, Centre Hospitalier Universitaire Lille, Department of Neurology, Lille, France. · Department of Clinical Neurosciences, University of Calgary, AB, Canada. · The Johns Hopkins University School of Medicine, Baltimore, MD, United States. · The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Neurology Department, Royal Prince Alfred Hospital, Sydney, NSW, Australia; The George Institute China at Peking University Health Science Center, Beijing, China. Electronic address: canderson@georgeinstitute.org.au. ·Lancet · Pubmed #30319113.

ABSTRACT: Acute spontaneous intracerebral haemorrhage is a life-threatening illness of global importance, with a poor prognosis and few proven treatments. As a heterogeneous disease, certain clinical and imaging features help identify the cause, prognosis, and how to manage the disease. Survival and recovery from intracerebral haemorrhage are related to the site, mass effect, and intracranial pressure from the underlying haematoma, and by subsequent cerebral oedema from perihaematomal neurotoxicity or inflammation and complications from prolonged neurological dysfunction. A moderate level of evidence supports there being beneficial effects of active management goals with avoidance of early palliative care orders, well-coordinated specialist stroke unit care, targeted neurointensive and surgical interventions, early control of elevated blood pressure, and rapid reversal of abnormal coagulation.

24 Review Should Hypertension Be Treated in Late Life to Preserve Cognitive Function? Con Side of the Argument. 2018

Gottesman, Rebecca F. ·From the Departments of Neurology and Epidemiology, Johns Hopkins University, Baltimore, MD. rgottesm@jhmi.edu. ·Hypertension · Pubmed #29643178.

ABSTRACT: -- No abstract --

25 Review Should Hypertension Be Treated in Late Life to Preserve Cognitive Function? Pro Side of the Argument. 2018

Wright, Clinton B. ·From the National Institute of Neurological Disorders and Stroke, Rockville, MD. wright.clinton@gmail.com. ·Hypertension · Pubmed #29643177.

ABSTRACT: -- No abstract --